Targeting Atherosclerosis with pH-Responsive Nanocarrier | ELA-11 Peptide Modulates Macrophage Function for Improved Treatment

In this episode of SciBud, we take a closer look at groundbreaking research that could revolutionize how we combat atherosclerosis—a key contributor to heart attacks and strokes worldwide. Hosted by Rowan, we delve into the study's focus on a novel nanocarrier system, methoxy polyethylene glyco@Elabela-11 (mPEG@ELA-11), designed to deliver the peptide ELA-11 specifically to atherosclerotic plaques. This research reveals how ELA-11 modulates macrophage behavior, leveraging the AKT-ER stress pathway to reduce plaque formation and inflammation. Through insightful human data analyses and rigorous in vitro and in vivo experiments, the study unveils a promising new avenue for atheroprotective therapies, though it highlights the need for enhanced data accessibility for future reproducibility. Join us as we explore this exciting frontier in cardiovascular medicine, where cutting-edge nanotechnology meets molecular biology! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/278